Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon G Adler

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Kidney International|January 14, 2004
Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal diseaseKathy E Sietsema, Antonino Amato, Sharon G Adler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2009
Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal diseaseMadeleine V Pahl, Nosratola D Vaziri, Jun Yuan, et al.
Glomerular Diseases|October 9, 2025
Calcific Changes in an End-Stage Kidney following Long-Term Dialysis, Tertiary Hyperparathyroidism, and Treatment for Complement-Mediated Thrombotic Microangiopathy: A Case ReportKruti Gitesh Shah, Sharon G Adler, Tiane Dai, et al.
Molecular Biology Reports|September 24, 2013
Susceptibility gene search for nephropathy and related traits in Mexican-AmericansFarook Thameem, Issa A Kawalit, Sharon G Adler, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2004
Differential management of cardiovascular disease in ESRD by nephrologists and cardiologistsHamik A Martirosyan, Eric P Brass, Rajnish Mehrotra, et al.
Glomerular Diseases|November 2, 2023
The International Society of Glomerular Disease: Building the Future of Glomerular MedicineLaurel J Damashek, Sharon G Adler, Joshua M Tarnoff, et al.
Kidney International|October 9, 2003
Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control miceYoung-Sook Kim, Marpadga A Reddy, Linda Lanting, et al.
Nature Clinical Practice. Nephrology|September 18, 2008
Nodular glomerulosclerosis in a patient with metabolic syndrome without diabetesPierre Souraty, Cynthia C Nast, Rajnish Mehrotra, et al.
Nephron. Experimental Nephrology|January 14, 2011
The renin inhibitor aliskiren attenuates high-glucose induced extracellular matrix synthesis and prevents apoptosis in cultured podocytesLynetta M Phillips, Ying Wang, Tiane Dai, et al.
BMC Complementary and Alternative Medicine|November 16, 2010
Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLCJun Ma, Lynetta Phillips, Ying Wang, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Kidney International|January 14, 2004
Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal diseaseKathy E Sietsema, Antonino Amato, Sharon G Adler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2009
Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal diseaseMadeleine V Pahl, Nosratola D Vaziri, Jun Yuan, et al.
Glomerular Diseases|October 9, 2025
Calcific Changes in an End-Stage Kidney following Long-Term Dialysis, Tertiary Hyperparathyroidism, and Treatment for Complement-Mediated Thrombotic Microangiopathy: A Case ReportKruti Gitesh Shah, Sharon G Adler, Tiane Dai, et al.
Molecular Biology Reports|September 24, 2013
Susceptibility gene search for nephropathy and related traits in Mexican-AmericansFarook Thameem, Issa A Kawalit, Sharon G Adler, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2004
Differential management of cardiovascular disease in ESRD by nephrologists and cardiologistsHamik A Martirosyan, Eric P Brass, Rajnish Mehrotra, et al.
Glomerular Diseases|November 2, 2023
The International Society of Glomerular Disease: Building the Future of Glomerular MedicineLaurel J Damashek, Sharon G Adler, Joshua M Tarnoff, et al.
Kidney International|October 9, 2003
Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control miceYoung-Sook Kim, Marpadga A Reddy, Linda Lanting, et al.
Nature Clinical Practice. Nephrology|September 18, 2008
Nodular glomerulosclerosis in a patient with metabolic syndrome without diabetesPierre Souraty, Cynthia C Nast, Rajnish Mehrotra, et al.
Nephron. Experimental Nephrology|January 14, 2011
The renin inhibitor aliskiren attenuates high-glucose induced extracellular matrix synthesis and prevents apoptosis in cultured podocytesLynetta M Phillips, Ying Wang, Tiane Dai, et al.
BMC Complementary and Alternative Medicine|November 16, 2010
Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLCJun Ma, Lynetta Phillips, Ying Wang, et al.
Pageof 8